Publikationen

J Placke, D Schmidt: [Myxoid alteration of a cervical stroma cells : Mimicry of a tumor.]. Der Pathologe 01/2013; 34(4). DOI:10.1007/s00292-012-1722-5

Stefan Kommoss, Cyril Blake Gilks, Roland Penzel, Esther Herpel, Robertson Mackenzie, David Huntsman, Peter Schirmacher, Michael Anglesio, Dietmar Schmidt, Friedrich Kommoss: A current perspective on the pathological assessment of FOXL2 in adult-type granulosa cell tumours of the ovary. Histopathology 08/2013; 64(3). DOI:10.1111/his.12253

Stefan Kommoss, Jacobus Pfisterer, Alexander Reuss, Joachim Diebold, Steffen Hauptmann, Christine Schmidt, Andreas du Bois, Dietmar Schmidt, Friedrich Kommoss: Specialized Pathology Review in Patients With Ovarian Cancer Results From a Prospective Study. International Journal of Gynecological Cancer 10/2013; 23(8). DOI:10.1097/IGC.0b013e3182a01813

Hans Ikenberg, Christine Bergeron, Dietmar Schmidt, Henrik Griesser, Francisco Alameda, Claudio Angeloni, Johannes Bogers, Roger Dachez, Karin Denton, Jalil Hariri, Thomas Keller, Magnus von Knebel Doeberitz, Heinrich H Neumann, Luis M Puig-Tintore, Mario Sideri, Susanne Rehm, Ruediger Ridder: Screening for Cervical Cancer Precursors With p16/Ki-67 Dual-Stained Cytology: Results of the PALMS Study. Journal of the National Cancer Institute 10/2013; 105(20). DOI:10.1093/jnci/djt235

Hans Ikenberg, Christine Bergeron, Dietmar Schmidt, Henrik Griesser, Francisco Alameda, Claudio Angeloni, Johannes Bogers, Roger Dachez, Karin Denton, Jalil Hariri, Thomas Keller, Magnus von Knebel Doeberitz, Heinrich H. Neumann, Luis M. Puig-Tintore, Mario Sideri, Susanne Rehm, Ruediger Ridder: Screening for Cervical Cancer Precursors With p16/Ki-67 Dual-Stained Cytology: Results of the PALMS Study. JNCI Journal of the National Cancer Institute 10/2013; 105(20). DOI:10.1093/jnci/djt235.

Kern P, Kalisch A, Kolberg HC, Kimmig R, Otterbach F, von Minckwitz G, Sikov WM, Pott D, Kurbacher C. Neoadjuvant, anthracycline-free chemotherapy with carboplatin and docetaxel in triple-negative, early-stage breast cancer: a multicentric analysis of feasibility and rates of pathologic complete response. Chemotherapy. 2013;59(5):387-94.